London, UK - 18th June 2019 - NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, announces that all resolutions proposed at today's Annual General Meeting, were duly passed.
The full details of the vote will be disclosed on the website in due course.
# # #
For more information, please contact:
Ian Postlethwaite, CEO / CFO
Tel: +44 (0)20 3514 1800
WHIreland (NOMAD, Financial Adviser and Broker)
Chris Fielding / Jessica Cave
Tel: +44 (0)20 7220 1666
MO PR ADVISORY (Press Contact)
Tel: +44 (0)78 7644 4977
NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
Top stories from the Proactive Investors UK newsroom:
ANGLE PLC (LON:AGL) has received positive results from its Parsortix FDA clinical study for metastatic breast cancer. The 400-subject clinical study will support an application for Class II regulatory clearance for Parsortix in the...